MarketScreener Homepage > News > Sectors > Healthcare

News : Sectors

09/17	JOHNSON & JOHNSON : NY Files Charges Against J&J Over Opioids -- Update	DJ
09/17	JOHNSON & JOHNSON : NY Files Charges Against J&J Over Opioids	DJ
09/17	MERCK : Vaccinex Shares Climb 18% on Keytruda Collaboration With Merck	DJ
09/17	Bristol Myers, Dr. Reddy's Settle Revlimid U.S. Patent Litigation	DJ
09/17	U.S. plans for hundreds of millions of cheap, fast COVID-19 tests	RE
09/17	ELI LILLY AND : Lilly, Amgen to Collaborate on Making Lilly's Potential Covid-19 Antibody Therapies	DJ
09/17	TOP GLOVE BHD : looks to list in Hong Kong after 'supernormal' pandemic demand	RE
09/17	Alibaba Health, Sinovac partner on virus inoculation platform	RE
09/17	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Buy rating from JP Morgan	MD
09/17	MERCK KGAA : JP Morgan gives a Neutral rating	MD
09/17	BioNTech CEO expects vaccine can be fridge-stored for two weeks	RE
09/17	Takeda-led COVID-19 plasma product to begin trial this month	RE
09/17	MERCK KGAA : Credit Suisse gives a Buy rating	MD
09/16	SINOVAC BIOTECH : China's Sinovac to test coronavirus vaccine candidate in teenagers, children	RE
09/16	ASTRAZENECA : Italy could have AstraZeneca COVID-19 shots by end November, IRBM biotech says	RE

The best opportunities.
All the markets. Each month. In one click.

Discover

09/16	ASTRAZENECA : trial illnesses may not be due to COVID-19 shot - Oxford University	RE
09/16	MERCK KGAA : Bernstein remains Neutral	MD
09/16	NOVARTIS : ties bond sale to malaria treatment access in sustainability push	RE
09/16	MERCK : says it has overcome production shortages in vaccine materials	RE
09/16	ASTRAZENECA : trial illnesses may not be due to COVID-19 shot - Oxford Univ	RE
09/16	Illumina in talks to buy cancer testing startup Grail - Bloomberg News	RE
09/16	PHILIPS NV : Goldman Sachs gives a Buy rating	MD
09/16	GERRESHEIMER AG : Goldman Sachs maintains a Buy rating	MD
09/16	ELI LILLY AND : Covid-19 Antibody Drug Shown to Reduce Hospitalizations, Eli Lilly Says	DJ
09/16	ASTRAZENECA : Serum Institute gets approval to resume India trial of AstraZeneca COVID vaccine	RE
09/16	MERCK KGAA : JP Morgan sticks Neutral	MD
09/16	MERCK KGAA : Goldman Sachs reiterates its Sell rating	MD
09/16	TAKEDA PHARMACEUTICAL : Japan's Takeda to sell TachoSil surgical patch to Corza Health for 350 million euros	RE
09/16	MERCK : Confirms 2020 Outlook; Prioritizes Lower Debt	DJ
09/16	MERCK : Germany's Merck says it will focus on smaller takeovers	RE
09/16	CSL : Philippines says engaging Western pharma firms, despite Duterte anger	RE
09/15	ASTRAZENECA : U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate	RE
09/15	ASTRAZENECA : U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry	RE
09/15	ASTRAZENECA : U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry	RE
09/15	ASTRAZENECA : U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate	RE
09/15	ASTRAZENECA : Pfizer says coronavirus vaccine study shows mostly mild-to-moderate side effects	RE
09/15	BAYER : settles thousands of U.S. Roundup cases with trial attorneys	RE
09/15	REGENERON PHARMACEUTICALS : Roche exec says COVID-hit health systems at 'more or less' normal capacity	RE
09/15	Bayer settles thousands of U.S. Roundup cases with trial attorneys	RE
09/15	SOME VOLUNTEERS QUIT J&J COVID-19 TRIAL IN SPAIN AFTER ASTRAZENECA SCARE : investigator	RE
09/15	Germany grants BioNTech, CureVac $745 million to speed up COVID-19 vaccine work	RE
09/15	Tech, healthcare mega deals boost virus-stricken M&A market	RE
09/15	GILEAD SCIENCES : Magrolimab Gets FDA Breakthrough Therapy Designation in Myelodysplastic Syndrome	DJ
09/15	ELI LILLY AND : Lilly, Boehringer Ingelheim Get FDA Fast-Track Designation for Jardiance After Heart Attack	DJ
09/15	THERMO FISHER SCIENTIFIC : Expands Lab Plastics Production for Covid-19 Supplies	DJ
09/15	BAYER : Signs $25 Million License Agreement With US Company to Develop Breast Cancer Drug	DJ
09/15	BioNTech wins $445 million German grant for COVID-19 vaccine	RE
09/15	ASTRAZENECA : WHO praises AstraZeneca COVID-19 vaccine trial pause	RE
09/15	ROCHE HOLDINGS AG : Goldman Sachs keeps its Buy rating	MD
09/15	RELIEF THERAPEUTICS : sees top-line trial results for COVID-19 treatment in early Q4	RE
09/15	MERCK : Makes $1 Billion Deal	DJ
09/15	ROCHE HOLDINGS AG : Buy rating from JP Morgan	MD
09/15	Tech leads crisis-driven M&A boom with $350 billion deal rush	RE
09/15	MERCK KGAA : JP Morgan remains Neutral	MD
09/14	South Korea to secure coronavirus vaccines for 60% of population	RE
09/14	Asian stocks head higher on China data, markets eye Fed meeting	RE
09/14	EXCLUSIVE : AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sources	RE
09/14	Tencent, others to buy $516.12 million worth shares in China Evergrande New Energy Vehicle	RE
09/14	ELI LILLY AND : U.S. Coronavirus Infections Fall From a Day Earlier -- 3rd Update	DJ
09/14	MARINUS PHARMACEUTICALS : genetic epilepsy drug meets main goal of late-stage study	RE
09/14	GILEAD SCIENCES : COVID SCIENCE-Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen	RE
09/14	AstraZeneca COVID-19 vaccine trials resume in Brazil	RE
09/14	Tech leads crisis-driven M&A boom with $350 billion deal rush	RE
09/14	Eli Lilly's drug cuts COVID-19 recovery time in remdesivir-combo study	RE
09/14	Gilead's shares rise after $21 billion deal for Immunomedics	RE

The best opportunities.
All the markets. Each month. In one click.

Discover

09/14	ROCHE : exec criticises Trump drug price order, says 'exceeds authority'	RE
09/14	Hospitalized Covid-19 Patients Recovered Faster With Arthritis Drug	DJ
09/14	ROCHE : drugs chief criticises Trump drug price order, says 'exceeds authority'	RE
09/14	Merck to buy $1 billion stake in Seattle Genetics, co-develop cancer therapy	RE
09/14	NEUROCRINE BIOSCIENCES : launches Parkinson's therapy as COVID-19 related disruptions ease	RE

Prev.1 2 3 4 5 6 7 8 9 10 Next

MOST READ NEWS

1	ASTRAZENECA PLC : COVID-19 vaccine verdicts loom as next big market risk
2	ROCHE HOLDING AG : ROCHE HOLDINGS AG : Goldman Sachs gives a Buy rating
3	KOREAN AIR LINES CO.,LTD. : HOW A FORTUNATE FEW AIRLINES PROFIT IN A PANDEMIC: Lots of Cargo
4	Nikola’s turmoil was bound to happen
5	AMERICAN WELL CORPORATION : AMERICAN WELL CORP : Entry into a Material Definitive Agreement, Unregistered Sale..